MedPath

Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities

Not Applicable
Completed
Conditions
Dyslipidemia
Oxidative Stress
Interventions
Dietary Supplement: Brazil nut flour
Dietary Supplement: Placebo (cassava flavored flour)
Registration Number
NCT01990391
Lead Sponsor
Universidade Federal do Rio de Janeiro
Brief Summary

The purpose this research is to check the effect of Brazil Nuts consumption in oxidative stress, metabolic abnormalities and microvascular endothelial function dyslipidemic and hypertensive patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • adults > 20 years old
  • Dyslipidemic
  • Hypertensive
Exclusion Criteria
  • Allergy to nuts
  • Consumption of nuts or vitamins/minerals supplement
  • Loss weight before the research
  • pregnancy
  • Kidney chronic disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Cassava flavored flourBrazil nut flourThe placebo group (cassava flour flavored) received 9g/day of cassava flour flavored during three months (12 weeks)
Brazil nut flourPlacebo (cassava flavored flour)The Brazil nut group received 13g/day of Brazil nut flour during three months (12 weeks)
Primary Outcome Measures
NameTimeMethod
Antioxidant biomarkerChange from Baseline at 12 weeks.

Change from Baseline plasma Gluthathione Peroxidase activity (nmol/min/ml) at 12 weeks, samples were stocked at -80 degrees.

Secondary Outcome Measures
NameTimeMethod
Oxidative stress biomarkerChange from Baseline at 12 weeks.

The change from baseline plasma 8-isoprostane (pg/ml) at 12 weeks, samples were stocked at -80 degrees.

microvascular endothelial functionChange from baseline at 12 weeks

Microvascular reactivity was evaluated using an Laser Speckle Contrast Imaging system with a laser wavelength of 785 nm in combination with the iontophoresis (increasing anodal currents of 30, 60, 90, 120, 150 and 180μA for 10 second intervals spaced 1 minute apart) of acetylcholine (2% v/v) for the noninvasive and continuous measurement of cutaneous microvascular perfusion changes measured in arbitrary perfusion units.

© Copyright 2025. All Rights Reserved by MedPath